Diabetes
is a metabolic disorder arising mainly due to the fault in the production of
insulin or mounting resistance to its action. In the case of Diabetes, the most
serious problem is the side effect, which occurs due to the accumulation of
glucose. This excess glucose is converted into various compounds and also into
free radicals, which damage the vital organs and organelles. Diabetes was
seriously underrated as a threat to global public health until very recently.
Today, Diabetes now ranks as one of the greatest public health challenges in
the history of mankind. There were 382 million people with Diabetes, or 8.3% of
the global population, in 2013. By 2035, this number will be 10.1%, equal
almost 600 million people worldwide.
Diabetes
has a very large economic impact. For example, in the US the cost of diagnosed
Diabetes in 2012 is estimated at US$245 billion, including $176 billion in
direct medical costs. In 2013, the average Diabetes related expenditures per
person in the US was USD9,800. Globally, per capita Diabetes related
expenditures in 2013 was USD1,436. Further, the global market for Diabetes
medications is estimated at approximately USD45 billion in 2013 and is growing
10.5% annually overall, with insulin sales increasing at a 14.2% CAGR.
The
currently available antidiabetic drugs manage the blood glucose levels under
normal range by supplementing insulin, improving insulin sensitivity,
increasing insulin secretion from the pancreas, decreasing glucose absorption
from the intestinal tract and/or glucose uptake by tissue cells.
Today,
the management of Diabetes without any side effect is still a challenge to the
medical fraternity. However, a wide array of plant-derived active principles
has demonstrated antidiabetic activity. These natural medicines modulate blood
sugar levels through a variety of mechanisms. In some cases their effects are
similar to conventional medicines.
This
report looks at the use of medicinal plants, rather than pharmaceutical drugs,
to both prevent and treat Diabetes. Specifically, it looks in detail at one of
these plants: Cinnamon. Cinnamon is widely used and available and the market
for it is well developed. The modern literature indicates that the potential
antidiabetic properties of Cinnamon have been studied for over 20 years.
Numerous trials have been conducted in humans to determine the metabolic
effects of Cinnamon.
Global production of
Cinnamon is forecast to rise 15% annually in value, and 6% annually in volume,
between 2014 and 2019. The report provides the following additional
information:
A detailed look at the Diabetes market including its incidence by country now
and during the next 20 years, economic impacts and costs by type, especially
medications.
Analysis of medicinal plants to manage Diabetes including experimental studies
on the hypoglycaemic activity and bioactive components of 66 plants.
The potential of Cinnamon for the management of Diabetes including its
biological effects, molecular mechanisms of action and clinical studies.
Analysis of the global market for Cinnamon including production, imports,
exports and traders.
Spanning
over 328 pages “Diabetes: Herbal
Bioactive Molecules Vs. Pharmaceutical Drugs– Volume 1: Cinnamon Global
Markets, Competitors And Opportunities- 2014-2019 Analysis And Forecast” report
Covering the Executive Summary, Introduction, Diabetes Market Overview,
Medicinal Plants and Diabetes, Cinnamon and Diabetes, Cinnamon Market Overview,
Company Profiles, Appendix 1: Diabetes Overview, Appendix 2: Insulin Overview.
Know more about this
report at
– http://mrr.cm/Ztk
Find all Pharmaceutical
Manufacturing Reports at:
